Patent Number
US 12064432B2
Abstract
The present disclosure provides compositions comprising a lyn kinase activator and TRPM8 agonist, and to methods of: reducing blood glucose levels, weight gain, or fat depot levels; treating metabolic syndrome, Syndrome X, obesity, prediabetes, type II diabetes, type I diabetes; treating hypercholesterolemia, hypertension, coronary heart disease, diabetic neuropathy, lipodystrophy, diabetic retinopathy, erectile dysfunction, kidney disease, dyslipidemia, dyslipoproteinemia, a peroxisome proliferator activated receptor-associated disorder, septicemia, a thrombotic disorder, or pancreatitis; inducing the beiging of adipocytes; and preventing pancreatic beta cell degeneration.
Application Number
17/993,216
Assignees
Melior Pharmaceuticals Inc.; Louisiana State University
Publication Date
8-20-2024
Recommended Citation
Reaume, A. G., Cong, W., Greenway, F., & Coulter, A. (2024). Treatment of Adipocytes. Retrieved from https://repository.lsu.edu/pbrc_patents/1